Literature DB >> 18618227

Eosinophilia and first-line coagulation testing.

Giuseppe Lippi1, Martina Montagnana, Gian Luca Salvagno, Massimo Franchini, Giovanni Targher, Gian Cesare Guidi.   

Abstract

Although eosinophilia (eosinophil count >0.60 x 10(9)/l), is a prothrombotic condition, little is known on the association between eosinophil count in blood and first-line coagulations tests, including fibrinogen, activated partial thromboplastin time (APTT), prothrombin time (PT) and platelet count. Cumulative results of APTT, PT, fibrinogen, platelet and eosinophil counts were retrieved from 6,944 outpatients >15 years old referred to our laboratory for routine blood testing over the previous 3 years. The median value and the percentage of patients with abnormal values of platelet count and fibrinogen but not APTT and PT, were significantly higher in patients with eosinophilia. This epidemiological association in a large subset of patients provides an additional potential mechanism to explain the link between eosinophilia and thrombosis and is consistent with the hypothesis that platelet count and fibrinogen might be worthwhile assessing in the presence of an abnormal eosinophil count.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618227     DOI: 10.1007/s11239-008-0247-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

1.  Tumor-associated eosinophilotactic factor.

Authors:  S I Wasserman; E J Goetzl; L Ellman; K F Austen
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

Review 2.  Diagnostic approach to inherited bleeding disorders.

Authors:  Giuseppe Lippi; Massimo Franchini; Gian Cesare Guidi
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

3.  Deep venous thrombosis in hypereosinophilic syndrome.

Authors:  O Valente; M A Scarpinella-Bueno
Journal:  Am Fam Physician       Date:  1994-10       Impact factor: 3.292

4.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

5.  Cutaneous microthrombi: a histologic clue to the diagnosis of hypereosinophilic syndrome.

Authors:  J E Fitzpatrick; C Johnson; P Simon; J Owenby
Journal:  Am J Dermatopathol       Date:  1987-10       Impact factor: 1.533

6.  Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease.

Authors:  A Slungaard; G M Vercellotti; T Tran; G J Gleich; N S Key
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Thromboembolism in a patient with transient eosinophilia.

Authors:  H Y Mukai; H Ninomiya; S Mitsuhashi; Y Hasegawa; T Nagasawa; T Abe
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

8.  Eosinophilia: A study of 100 hospitalized patients.

Authors:  Kobi Sade; Alex Mysels; Yoram Levo; Shmuel Kivity
Journal:  Eur J Intern Med       Date:  2007-05       Impact factor: 4.487

9.  Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.

Authors:  D L Wassom; D A Loegering; G O Solley; S B Moore; R T Schooley; A S Fauci; G J Gleich
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

10.  Activation of platelets by eosinophil granule proteins.

Authors:  M S Rohrbach; C L Wheatley; N R Slifman; G J Gleich
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  6 in total

1.  Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.

Authors:  A V Marzano; A Tedeschi; E Berti; D Fanoni; C Crosti; M Cugno
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

2.  Significance of eosinophil accumulation in the thrombus and decrease in peripheral blood in patients with acute coronary syndrome.

Authors:  Ping Jiang; De-zhao Wang; Ya-li Ren; Jian-ping Cai; Bu-xing Chen
Journal:  Coron Artery Dis       Date:  2015-03       Impact factor: 1.439

3.  Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study.

Authors:  Marzyeh Amini; Dinara Bashirova; Bram P Prins; Eva Corpeleijn; Marcel Bruinenberg; Lude Franke; Pim van der Harst; Gerjan Navis; Bruce H R Wolffenbuttel; Ronald P Stolk; Cisca Wijmenga; Dirkje S Postma; Gerard H Koppelman; H Marike Boezen; Judith Vonk; Harold Snieder; Behrooz Z Alizadeh
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

4.  Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome.

Authors:  Dezhi Li; Li Xu; Dianjie Lin; Shujuan Jiang; Saran Feng; Ling Zhu
Journal:  Respir Med Case Rep       Date:  2018-09-10

5.  Portal Vein Thrombosis and Thrombocytopenia in Eosinophilic Granulomatosis with Polyangiitis: A Paradox?

Authors:  Frieda Wolf; Karina Glick; Mazen Elias; Reuven Mader
Journal:  Eur J Case Rep Intern Med       Date:  2018-11-28

6.  Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.

Authors:  Haoye Cai; Honghao Huang; Chenguang Yang; Junli Ren; Jianing Wang; Beibei Gao; Wenjing Pan; Fangyue Sun; Xinbo Zhou; Tian Zeng; Jingyu Hu; Yilin Chen; Shunkai Zhang; Guangyong Chen
Journal:  Front Neurol       Date:  2021-07-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.